ArticleJournal for immunotherapy of cancer2024

Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma.

Ryan P O'Connell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.